No abstract available
MeSH terms
-
Anti-HIV Agents / adverse effects
-
Anti-HIV Agents / therapeutic use*
-
CCR5 Receptor Antagonists*
-
Clinical Trials, Phase II as Topic
-
HIV Infections / drug therapy*
-
Humans
-
Piperazines / adverse effects
-
Piperazines / therapeutic use*
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use*
-
Receptors, CCR5 / immunology
-
Treatment Outcome
Substances
-
Anti-HIV Agents
-
CCR5 Receptor Antagonists
-
Piperazines
-
Pyrimidines
-
Receptors, CCR5
-
vicriviroc